High Tower Advisors, LLC United Therapeutics Corp Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

A detailed history of High Tower Advisors, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, High Tower Advisors, LLC holds 18,050 shares of UTHR stock, worth $6.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,050

Previous 16,915 6.71%

Holding current value

$6.56 Million

Previous $5.39 Million 20.04%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $353,030 - $412,629	1,135 Added 6.71%	18,050 $6.47 Million
Q2 2024 Aug 13, 2024	BUY	$228.26 - $319.04 $2.74 Million - $3.83 Million	12,001 Added 244.22%	16,915 $5.39 Million
Q1 2024 May 06, 2024	SELL	$210.76 - $249.51 $137,204 - $162,431	-651 Reduced 11.7%	4,914 $1.13 Million
Q4 2023 Feb 12, 2024	BUY	$214.88 - $256.94 $284,930 - $340,702	1,326 Added 31.28%	5,565 $1.22 Million
Q3 2023 Nov 08, 2023	BUY	$211.82 - $248.24 $189,578 - $222,174	895 Added 26.76%	4,239 $957,000
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $463,524 - $526,324	2,259 Added 208.2%	3,344 $738,000
Q1 2023 May 11, 2023	SELL	$212.99 - $276.17 $31,522 - $40,873	-148 Reduced 12.0%	1,085 $242,000
Q4 2022 Feb 08, 2023	BUY	$205.95 - $280.43 $253,936 - $345,770	1,233 New	1,233 $342,000
Q2 2022 Aug 10, 2022	BUY	$174.81 - $241.14 $164,321 - $226,671	940 New	940 $221,000
Q4 2020 Feb 10, 2021	SELL	$101.87 - $151.79 $658,385 - $981,018	-6,463 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$99.9 - $121.13 $5,094 - $6,177	51 Added 0.8%	6,463 $653,000
Q2 2020 Aug 10, 2020	SELL	$92.74 - $125.82 $8,068 - $10,946	-87 Reduced 1.34%	6,412 $776,000
Q1 2020 May 21, 2020	BUY	$79.39 - $115.35 $20,879 - $30,337	263 Added 4.22%	6,499 $617,000
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $156 - $190	-2 Reduced 0.03%	6,236 $549,000
Q3 2019 Nov 12, 2019	SELL	$74.85 - $85.99 $446,105 - $512,500	-5,960 Reduced 48.86%	6,238 $497,000
Q2 2019 Aug 13, 2019	SELL	$76.06 - $120.81 $1.01 Million - $1.6 Million	-13,216 Reduced 52.0%	12,198 $945,000
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $78,648 - $93,100	-734 Reduced 2.81%	25,414 $3.04 Million
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $36,909 - $46,857	-364 Reduced 1.37%	26,148 $2.81 Million
Q3 2018 Nov 09, 2018	SELL	$113.81 - $129.46 $77,732 - $88,421	-683 Reduced 2.51%	26,512 $3.43 Million
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $543,930 - $636,271	-5,378 Reduced 16.51%	27,195 $3.04 Million
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $408,470 - $578,891	-3,810 Reduced 10.47%	32,573 $3.6 Million
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $412,421 - $526,151	3,478 Added 10.57%	36,383 $5.33 Million
Q3 2017 Nov 14, 2017	SELL	$114.6 - $136.81 $172,473 - $205,899	-1,505 Reduced 4.37%	32,905 $3.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	34,410	34,410 $4.43 Million

Others Institutions Holding UTHR

# of Institutions

667

Shares Held

42.7M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC United Therapeutics Corp Transaction History